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Objective: To objectively evaluate the effectiveness of psychological interventions for
improving health-related quality of life in patientswith systemic lupus erythematosus (SLE).
Design and review methods: Databases including Ovid-Medline, PubMed, Web of Science,
EBSCOhost, the Cochrane Library and Embase were electronically searched to identify
randomized controlled trials published from inception through November 2013 involving
psychological intervention in SLE patients. Studies that measured physiological function,
life vitality, depression, pain degree, disease activity, severity of fatigue, and physical and
mental component summaries as outcomes were included. Trials involving patients with
multiple diseases or received simultaneous psychological interventions or combinations of
other interventions were excluded. Two independent investigators screened the identified
articles, extracted the data, and assessed the methodological quality of the included
studies. Qualitative descriptions were conducted and quantitative analysis was performed
with RevMan software (version 5.2).
Results: A total of six randomized controlled trials comprising 394 participants were
included in the study. Meta-analyses showed that psychological interventions significantly
reduced the degree of depression (standard mean difference ¼ 0.44, 95% confidence in-
terval [CI]: 0.78e0.10; P ¼ 0.01] and improved the status of the physical health component
summary (mean difference ¼ 8.85, 95%CI: 3.69e14.00; P ¼ 0.00] in SLE patients. However,
there was no significant effect of psychological intervention on disease activity, degree of
pain, fatigue or the mental health component summary.
Conclusions: The results show that psychological interventions can effectively improve the
health-related quality of life in patients with SLE. The full benefit and clinical performance
of psychological care requires further investigation by a series of multicenter, large-sample
size randomized controlled trails.
Copyright © 2014, Chinese Nursing Association. Production and hosting by Elsevier
(Singapore) Pte Ltd. All rights reserved..-M. Wang).
Nursing Association.
g Association. Production and hosting by Elsevier (Singapore) Pte Ltd. All rights reserved.
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neous, multi-system autoimmune disease that is persistent
and recurrent [1,2]. The clinical symptoms of SLE are difficult
to predict, and include neurological symptoms (e.g., anxiety
and depression, cognitive disorders and psychosis), fatigue,
skin rashes, joint pain, headaches, epilepsy, cerebral vascular
accidents, and movement disorders [3]. SLE is more frequent
among women and individuals of African ancestry [4,5], with
an incidence of 4.8e8.7 cases per 100,000 habitants in Brazil
[6,7]. There is no known specific etiology of SLE, though its
development is likely influenced by genetic, hormonal, envi-
ronmental, and drug factors.
Although SLE is not a fatal condition, the lack of a curative
therapy leaves most patients with a long-term sickness,
which can negatively affect their emotional, psychological
and social functioning and quality of life. The disease activity
status and the incidence of organ damage correlate with SLE
patient quality of life, which is thus a key focus of ongoing
research [8]. Furthermore, a poor psychological status may
aggravate the clinical manifestation of SLE and promote dis-
ease progression [9]. There is accumulating evidence that
psychological intervention is effective for improving the
health-related quality of life (HRQOL) inpatients with Parkin-
son's disease, pediatric malignancy, and cancer [10e12], as
well as those who have undergone liver transplantation [13].
Moreover, psychological intervention is reported to be the
most effective method to improve HRQOL in adolescents with
juvenile idiopathic arthritis [14]. A study conducted of patients
in Sweden found that patients with SLE are likely to report a
low HRQOL and high medical costs that correspond with dis-
ease activity [15]. However, additional studies that used the
Systemic Lupus Disease Activity Index (SLEDAI), which re-
ports on 24 descriptors with pre-assigned severity weights to
evaluate lupus activity, found no correlation between HRQOL
and disease activity, suggesting that disease activity, cumu-
lative damage and QOL are independent outcome indicators
[16,17].
The HRQOL of SLE patients can be evaluated by a variety of
assessment methods, of which the Medical Outcomes Survey
Short Form 36 (SF-36) is the most common [18]. Additionally,
LupusPRO is a disease-targeted, patient-reported outcome
measure developed for and validated in American patients
with SLE [19,20] with adequate psychometric properties for
SLE patients in the Philippines [21], and was translated and
adapted for use in Spanish-speaking patients [22]. The
LupusQOL(c) and SF-36 were useful for assessing HRQOL in
Mexican female patients with SLE, though the LupusQOL(c)
should be evaluated for use in patients with moderately se-
vere disease activity [23].
With these assessment methods in hand, the effects of
psychological intervention on HRQOL in SLE patients can be
evaluated. Furthermore, the patient's psychological, person-
ality or behavioral problems can be examined, such that the
most effective intervention can be identified. The present
study followed the population, intervention, comparison and
outcome method to evaluate psychological interventions in
patients with SLE. Psychological interventions providedregardless of health-care setting were compared with con-
ventional therapy, and the outcomes of interest included
disease activity, degree of pain, severity of fatigue, depression,
physical component summary (PCS) and mental component
summary (MCS).2. Methods
2.1. Search strategy
The electronic databases Ovid-Medline, PubMed, Web of Sci-
ence, EBSCOhost, the Cochrane Library and Embase were
searched for English-language randomized controlled trials
using combinations of the following terms: psychotherapy,
psychology, psychological, psycho-education, behavior
therapy, cognitive therapy, cognitive behavioral therapy,
health-related quality of life, HRQOL, QOL, systemic lupus
erythematosus, lupus, SLE. In addition, references from
related systematic reviews and meta-analyses retrieved from
these databases were searched for relevant publications.
2.2. Selection criteria
Each trial identified in the search was evaluated for design,
patient eligibility criteria, and outcome measures. Random-
ized controlled trials were eligible for inclusion in the sys-
tematic review if they utilized psychological interventions
(such as psychotherapy, psycho-education, behavioral or
cognitive therapies) for SLE patients (adults aged over 18 years
with a clinical diagnosis of SLE according to the American
College of Rheumatology (ACR) criteria [24]) and measured
physiological function, life vitality, depression, pain degree,
disease activity, severity of fatigue, PCS or MCS as outcomes.Fig. 1 e Flow chart of literature retrieval and trial selection.
Table 1 e Characteristics of included random controlled trials
Study Participants Age, y (mean ± SD) Study duration Intervention
(intervention/control)
Outcome Measurement
scaleIntervention Control
Dobkin et al. (2002)
Canada
Women with a diagnosis of SLE
according to ACR criteria
42.0 ± 11.2
n ¼ 64
43.0 ± 10.4
n ¼ 69
12 months Psychosocial measures/
Standard medical care
PCS
MCS
SF-36
Sohng (2003)
South Korea
Patients (>18 y) with at least
four of the ACR criteria for SLE
32.9 ± 11.8
n ¼ 21
42.3 ± 10.9
n ¼ 20
6 weeks SMS/Placebo Fatigue
Depression
Pain
Fatigue scale
BDI
VAS
Greco et al. (2004)
United States
Patients who met the 1982
revised ACR criteria for SLE
48.2 ± 9.1
n ¼ 32 (baseline),
26 (3/9 months)
47.0 ± 10.5
n ¼ 27 (baseline),
25 (3/9 months)
9 months SMS (standardized 6-session
protocol)/Placebo
Pain
Depression
Fatigue
Disease activity
AIMS2-Pain
MPI-I
CES-D
FSS
SLEDAI
Karlson et al. (2004)
United States
Patients (>18 y) who met the
ACR criteria for SLE
42.7 ± 22.8
n ¼ 64 (baseline),
46 (6 months),
41 (12 months)
40.8 ± 11.1
n ¼ 58 (baseline),
46 (6 months),
49 (12 months)
12 months One-hour education session
with a nurse/Placebo
Fatigue
PCS
MCS
SF-36
NavarreteeNavarrete
et al. (2010a)
Spain
Patients with at least four of the
ACR criteria for SLE
43.8 ± 9.9
n ¼ 21
40.4 ± 10.7
n ¼ 24
15 months Cognitive behavioral therapy/
Standard medical care
Depression
Pain
Disease Activity
BDI
SLEDAI
SF-36
NavarreteeNavarrete
et al. (2010b)
Spain
Patients with at least four of the
ACR criteria for SLE
43.3 ± 10.7
n ¼ 18
37.2 ± 9.1
n ¼ 16
3/9/15 months Cognitive behavioral therapy/
Standard medical care
Pain
PCS
MCS
SF-36
Abbreviations: ACR, American College of Rheumatology; AIMS2-Pain, Arthritis Impact Measurement Scale-Pain Subscale; BDI, Beck Depression Inventory; CES-D, Center for Epidemiological Study-
Depression; FSS, Fatigue Severity Scale; MPI-I, Multidimensional Pain Inventory; MCS, mental component summary; PCS, physical component summary; SD, standard deviation; SF-36, Short Form 36-
item; SLE, systemic lupus erythematosusSLEDAI, SLE Disease Activity Index; SMS, self-management session; VAS, Visual Analog Scale.
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Fig. 2 e Meta-analyses.Results showing A) disease activity, B) pain, C) fatigue, D) depression, E) PCS, and F) MCS between
control and intervention groups.
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combinations of other interventions were excluded. Studies
reporting on patients with multiple disease diagnoses were
also excluded.
2.3. Data extraction and quality assessment
Searches were conducted and data extracted by two inde-
pendent investigators. Any discrepancy concerning the eligi-
bility of a trial was resolved via consulting a third investigator.
Duplicate studies and records were excluded based on
screening of titles and abstracts. The full text of all remaining
articles were then screened. The quality assessment of the
included trials was conducted by each investigator according
to the modified Jadad scale [25].
2.4. Statistical analysis
Outcome measures were compared between participants who
were treated with psychological intervention and the control
group within each study. The homogeneity among trials was
evaluated using I2, and a fixed effects model was used to
compare homogeneous trials (I2 < 50%), otherwise a random
effects model was used. Pooled differences in ratios or means
werecalculatedandatwo-tailedPvalue<0.05wasconsideredto
indicate statistical significance. Sensitivity analyses were con-
ducted using the leave-one-out approach, and publication bias
was assessed from Begg's and Egger's funnel plots. All analyses
were performed using ReviewManager Software (RevMan 5.2).3. Results
3.1. Study selection and characteristics
A total of 465 trials were identified by the initial literature
search (Fig. 1). Of these, six trials comprising 394 participants
were deemed eligible for inclusion in further analyses
(Table 1). Two of the eligible studies were conducted in the
United States [26,27], two studies were conducted in Spain
[29,30], one in Canada [31] and one study was from South
Korea [28]. Psychological interventions employed in these
studies included cognitive behavioral treatment (CBT),
theory-based educational, self-management, or psychosocial
interventions, and biofeedback-CBT. The duration of the
interventional programs ranged from 6 weeks to 15 months.
3.2. Disease activity
Two studies involving 96 participants [26,29] reported on dis-
ease activity after the intervention was initiated. A fixed ef-
fects model evaluation revealed no significant differences
between CBT and control groups in disease activity after three
or nine months of intervention (Fig. 2A).
3.3. Degree of pain
Four studies involving 171 SLE patients [26,28e30] reported on
the degree of pain. Because differing evaluations of pain were
used in the four trials, qualitative descriptions werecompared. Evaluation with a random effects model showed
that there was no statistically significant difference in pain
reported by participants receiving intervention compared
with controls (Fig. 2B).
3.4. Severity of fatigue
Three studies involving 182 SLE patients [26e28] reported on
fatigue. The use of varying evaluation methods among these
studies required that a narrative synthesis be conducted for
comparison. Analysis with a fixed effects model showed that
there was no statistically significant difference between pa-
tients receiving intervention or control treatment in level of
fatigue (Fig. 2C).
3.5. Depression
Three studies involving 137 SLE patients [26,28,29] evaluated
depression. Analysis using a fixed effects model revealed that
intervention with CBT significantly reduced measures of
depression (P ¼ 0.01) (Fig. 2D).
3.6. PCS
Three studies involving 257 SLE patients [27,30,31] reported on
PCS. Analysis with a fixed effects model revealed that PCS
measures were significantly increased among SLE patients
receiving psychological intervention compared to control
treatments (P ¼ 0.00) (Fig. 2E).
3.7. MCS
Three studies involving 257 SLE patients [27,30,31] reported on
MCS. Analysis with a random effectsmodel revealed that MCS
values did not significantly differ between intervention and
control groups (Fig. 2F).
3.8. Quality assessment
All of the six studies included in this meta-analysis were
randomized controlled trials. Although allocation conceal-
ment was unclear for all of the included articles, incomplete
outcome data or other potential biases were addressed by
each of the studies (Fig. 3).
3.9. Publication bias
The four studies that reported on pain degree were used to
assess publication bias. No bias was indicated by a rank cor-
relation (Begg's) test (Z ¼ 1.02, P ¼ 0.31) (Fig. 4A) or linear
regression (Egger's) test (t ¼ 2.94, P ¼ 0.10) (Fig. 4B).4. Discussion
The results of this study show that psychological in-
terventions can have a significant impact on physical but not
mental component summaries, which is consistent with
previous reports [32e34]. In another study, intervention con-
sisting of psycho-educational elements produced a significant
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Fig. 3 e Risk of bias summary. Authors' judgments about
each risk of bias item for each included study.
Fig. 4 e Funnel plots for publication bias. A) Begg's funnel
plot. B) Egger's funnel plot; s.e., standard error; SMD,
standard mean difference.
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improvements by CBT were observed in PCS and depression
values, but not in assessments of disease activity, degree of
pain, fatigue and MCS, though their trends were in the ex-
pected direction. These findings suggest that depression has a
significant impact on the HRQOL in SLE patients. In the study,
CBT had a greater effect comparedwith standardmedical care
on the frequency of depression symptoms over the past week
in SLE patients, measured using the Center for Epidemiolog-
ical Study Depression scale [26].
CBT intervention was reported to reduce the severity of
pain in SLE patients as assessed by the Revised Arthritis
Impact Measurement Scale-Pain Subscale and the Multidi-
mensional Pain Inventory [26], as well as using the SF-36
[29,30]. However, comparison among the studies in our anal-
ysis indicated that the improvements observed did not reach
significance. Similarly, psychological interventions have been
reported to improve fatigue in SLE patients as assessed by a
nine-item Fatigue Severity Scale [26], the SF-36 [27], and the
Multidimensional Assessment of Fatigue Scale [28], which
were not significant based on our meta-analysis.
Despite the insight into SLE patients' HRQOL, further study
is needed to confirm or clarify results in many areas [36].
Research has demonstrated that additional support and in-
terventions are needed to reduce the symptom load in SLE
patients and improve their HRQOL [37]. This is particularly
important for pediatric cases, which comprise15e20% of SLE
patients [38,39], and can be significant during their transition
to adult rheumatology care [40]. The enormous psychological
and social impact of the disease and its treatments upon the
child or young person and their family necessitates a
comprehensive, holistic, specialized multidisciplinary
approach [41]. Indeed, a specialized disease rating scale had
been developed, the Simple Measure of Impact of Lupus Ery-
thematosus in Youngsters scale, which was validated by a
multi-center cross-sectional study of children and adoles-
cents 5e18 years of age with SLE in Brazil [42]. Future studies
should therefore include pediatric SLE patients.5. Limitations
There are a number of limitations to this systematic review
that should be acknowledged. First, and perhaps most
notably, only a small number of trials met the inclusion
criteria, thus reducing the power of the analyses. The inclu-
sion of only English-language literature may also have
restricted the number of available relevant articles.6. Conclusion
In 1990, the quality of life was defined according to various
cultures and value systems by the World Health Organization
as encompassing personal goals, expectations, standards and
concerns related to the living conditions, including physical
and mental functions, role activities, social adaptability and
the overall feeling of health [32]. With the development of a
modern bio-psycho-social medical model, psychological care
also became very important in clinical nursing practice.
i n t e r n a t i o n a l j o u rn a l o f n u r s i n g s c i e n c e s 1 ( 2 0 1 4 ) 2 9 8e3 0 5304Healthcare workers are increasingly aware that interventions,
in addition to treating the physical damage caused by disease,
also address the patient's subjective feelings about living with
it. Historically, the psychological intervention has been an
adjunct treatment, and usually performed along with drug
therapy. The results of our systematic review show that psy-
chological intervention can effectively improve aspects of SLE
patients' QOL, and can enhance physiological function. In
summary, psychological intervention should be administered
to patients with SLE, which will not only provide beneficial
effects to the patients, but also allow for opportunities to
further evaluate specific effects in large-sample, multicenter
studies.Conflict of interest
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